|
Health Condition(s) or Problem
|
Cataract
|
|
Lay Summary
|
Sorry, not currently available
|
|
Who can enter the trial
|
1. Bilateral cataracts requiring surgery
2. Diabetic
3. Aged 18 years or over, either sex
|
|
Who cannot enter the trial
|
Diabetic maculopathy
|
|
What will happen
|
AVS hydrophobic intraocular lens versus AcrySof® intraocular lens. Patients will be randomised to have routine cataract surgery to one eye with implantation of either the Santen or the AcrySof® lens. Randomisation will be via a remote computer based website. Surgery to the second eye will be performed within 6 weeks of the first operation by the same surgeon, with the other intraocular lens type.
Patients will be followed up for a total of 3 years.
|
|
Primary aim
|
1. Glistenings
2. Vision
Taken at 1, 3, 6, 12, 24 and 36 months.
|
|
Secondary Aim
|
1. Post-operative inflammation after cataract surgery and cellular deposition on the IOL surface
2. Objective optical quality and wave-front aberration
3. Contrast sensitivity
4. Diabetic retinopathy after cataract surgery
Taken at 1, 3, 6, 12, 24 and 36 months.
|
|
Participant Information Sheet
|
Not available in web format, please use the contact details below to request a patient information sheet
|
|
Website
|
Sorry, not currently available
|
|
Recruitment Status
|
Completed
|
|
Nation
|
England
|
|
Location
|
London
|